Bayesian Capital Management, LP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$150,738
-37.5%
19,400
-11.8%
0.02%
-43.3%
Q1 2023$241,120
-25.3%
22,000
-31.6%
0.03%
-50.0%
Q2 2022$323,000
+280.0%
32,183
+97.4%
0.06%
+172.7%
Q1 2018$85,00016,3000.02%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 230,000$993,6001.92%
AlphaCentric Advisors LLC 352,500$1,522,8001.50%
NEA Management Company, LLC 3,969,834$17,149,6830.96%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 573,530$2,477,6500.76%
ARMISTICE CAPITAL, LLC 5,000,000$21,600,0000.38%
IRONWOOD INVESTMENT MANAGEMENT LLC 93,658$404,6030.27%
Artal Group S.A. 1,000,000$4,3200.24%
Virtus ETF Advisers LLC 64,786$279,8760.15%
TANG CAPITAL MANAGEMENT LLC 200,000$864,0000.13%
HighMark Wealth Management LLC 37,499$161,9960.12%
View complete list of AURINIA PHARMACEUTICALS INC shareholders